2024 ICD-10-CM Diagnosis Code E83.39

Other disorders of phosphorus metabolism

ICD-10-CM Code:
ICD-10 Code for:
Other disorders of phosphorus metabolism
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Code Navigator:

Code Classification

  • Endocrine, nutritional and metabolic diseases
    • Metabolic disorders
      • Disorders of mineral metabolism

E83.39 is a billable diagnosis code used to specify a medical diagnosis of other disorders of phosphorus metabolism. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Acid phosphatase deficiency
  • Acquired hypophosphatemia
  • Acquired hypophosphatemia
  • Adult hypophosphatasia
  • Alkaline phosphatase above reference range
  • Childhood hypophosphatasia
  • Chronic myopathy with hypocalcemia and hypophosphatemia
  • Hyperphosphatasemia with bone disease
  • Hyperphosphatasemia with intellectual disability
  • Hyperphosphatemia
  • Hyperphosphatemia
  • Hyperphosphatemia
  • Hyperphosphatemia due to chronic kidney disease
  • Hyperphosphaturia
  • Hypophosphatasia
  • Hypophosphatasia rickets
  • Hypophosphatemia
  • Hypophosphatemia due to chronic kidney disease
  • Hypophosphaturia
  • Iatrogenic hyperphosphatemia
  • Idiopathic hyperphosphatasemia
  • Infantile hypophosphatasia
  • Nutritional hypophosphatemia
  • Odontohypophosphatasia
  • Periodontitis exacerbated by hypophosphatasia
  • Renal failure-associated hyperphosphatemia
  • Renal failure-associated hyperphosphatemia
  • Renal phosphaturia

Clinical Classification

Clinical Information

  • Hypophosphatasia

    a genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. clinical manifestations include severe skeletal defects resembling vitamin d-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (from dorland, 27th ed)
  • Hyperphosphatemia

    a condition of abnormally high level of phosphates in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
  • Familial Hypophosphatemic Rickets

    a hereditary disorder characterized by hypophosphatemia; rickets; osteomalacia; renal defects in phosphate reabsorption and vitamin d metabolism; and growth retardation. autosomal and x-linked dominant and recessive variants have been reported.
  • Hypophosphatemia

    a condition of an abnormally low level of phosphates in the blood.
  • Hypophosphatemia, Familial

    an inherited condition of abnormally low serum levels of phosphates (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the proximal renal tubules. this leads to phosphaturia, hypophosphatemia, and disturbances of cellular and organ functions such as those in x-linked hypophosphatemic rickets; osteomalacia; and fanconi syndrome.
  • Rickets, Hypophosphatemic

    a disorder characterized by hypophosphatemia; rickets; osteomalacia; resulting from lack of phosphate reabsorption by the kidneys and possible defects in vitamin d metabolism.
  • Phosphates

    inorganic salts of phosphoric acid.
  • Hypophosphatasia

    a rare, serious metabolic disorder caused by mutations in the gene encoding tissue non-specific alkaline phosphatase (tnsalp) activity. it is characterized by low activity of tnsalp in the serum. the signs and symptoms vary significantly and include death in utero, failure to thrive, premature loss of deciduous teeth, early loss of the adult dentition, hypercalcemia, osteomalacia, skeletal defects, renal stones, and movement disorders.
  • Odontohypophosphatasia

    hypophosphastasia characterized by the premature loss of deciduous teeth, but without accompanying bony abnormalities.
  • Grade 1 Hyperphosphatemia, CTCAE|Grade 1 Hyperphosphatemia

    laboratory finding only and intervention not indicated
  • Grade 2 Hyperphosphatemia, CTCAE|Grade 2 Hyperphosphatemia

    noninvasive intervention indicated
  • Grade 3 Hyperphosphatemia, CTCAE|Grade 3 Hyperphosphatemia

    severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated
  • Grade 4 Hyperphosphatemia, CTCAE|Grade 4 Hyperphosphatemia

    life-threatening consequences; urgent intervention indicated (e.g., dialysis)
  • Grade 5 Hyperphosphatemia, CTCAE|Grade 5 Hyperphosphatemia

  • Hyperphosphatemia

    abnormally high level of phosphate in the blood.
  • Hyperphosphatemia, CTCAE|Hyperphosphatemia

    a disorder characterized by laboratory test results that indicate an elevation in the concentration of phosphate in a blood.
  • Autosomal Dominant Hypophosphatemia Rickets|Autosomal Dominant Hypophosphatemic Rickets|Autosomal Dominant Vitamin D-resistant Rickets

    an autosomal dominant renal phosphate wasting disorder that results in rickets.
  • Autosomal Recessive Hypophosphatemia Rickets|Autosomal Recessive Hypophosphatemic Rickets

    an autosomal recessive renal phosphate wasting disorder that results in rickets.
  • Fibroblast Growth Factor 23|FGF-23|Phosphatonin|Tumor-Derived Hypophosphatemia Inducing Factor|Tumor-Derived Hypophosphatemia-Inducing Factor

    fibroblast growth factor 23 (251 aa, ~28 kda) is encoded by the human fgf23 gene. this protein is involved in inhibition of renal tubular phosphate transport.
  • Grade 1 Hypophosphatemia, CTCAE|Grade 1 Hypophosphatemia

    laboratory finding only and intervention not indicated
  • Grade 2 Hypophosphatemia, CTCAE|Grade 2 Hypophosphatemia

    oral replacement therapy indicated
  • Grade 3 Hypophosphatemia, CTCAE|Grade 3 Hypophosphatemia

    severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated
  • Grade 4 Hypophosphatemia, CTCAE|Grade 4 Hypophosphatemia

    life-threatening consequences
  • Grade 5 Hypophosphatemia, CTCAE|Grade 5 Hypophosphatemia

  • Hypophosphatemia

    lower than normal levels of phosphates in the circulating blood.
  • Hypophosphatemia, CTCAE|Hypophosphatemia|Hypophosphatemia

    a disorder characterized by laboratory test results that indicate a low concentration of phosphates in the blood.
  • X-Linked Dominant Hypophosphatemic Rickets|Hereditary 1,25(OH)2D-resistant Rickets|Hypophosphatemic Vitamin D-resistant Rickets|Vitamin D-resistant Rickets|X-Linked Hypophosphatemia|X-linked Dominant Hypophosphatemic Rickets|X-linked Hypophosphatemic Rickets

    an x-linked dominant disorder caused by mutations in the phex gene. it is characterized by growth retardation, osteomalacia, hypophosphatemia, and defects in the renal reabsorption of phosphorus.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Acid phosphatase deficiency
  • Hypophosphatasia

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert E83.39 to ICD-9-CM

  • ICD-9-CM Code: 275.3 - Dis phosphorus metabol
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education

Metabolic Disorders

Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues, such as your liver, muscles, and body fat.

A metabolic disorder occurs when abnormal chemical reactions in your body disrupt this process. When this happens, you might have too much of some substances or too little of other ones that you need to stay healthy. There are different groups of disorders. Some affect the breakdown of amino acids, carbohydrates, or lipids. Another group, mitochondrial diseases, affects the parts of the cells that produce the energy.

You can develop a metabolic disorder when some organs, such as your liver or pancreas, become diseased or do not function normally. Diabetes is an example.

[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.


[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.